Ending pediatric AIDS and achieving the Super-Fast-Track targets for pediatric HIV requires intensified efforts to rapidly identify and treat HIV-positive infants and young children. In 2017, only 51 percent of all HIV-exposed infants were tested for HIV within the recommended first two months of life, and only 52 percent of children living with HIV received lifesaving antiretroviral therapy (ART). Without access to timely diagnosis and treatment, up to 30 percent of HIV-infected children will die by their first birthday, and 50 percent will die by their second birthday.
Explore Related Resources
Malawi landscape
Poster
Twenty-Four-Month Survival Among Patients with Cryptococcal Antigenemia Enrolled in Malawi’s Advanced HIV Disease Program: A Retrospective Cohort Study
Published August 2026
We assessed 24-month survival and factors associated with mortality among AHD clients with cryptococcal antigenemia enrolled in Malawi’s AHD program.
View Resource
Topics:
Advanced HIV Disease (AHD)
Countries:
Malawi
Poster
From Mortality Review to Mortality Reduction: The Importance of Embedding Routine Pediatric HIV Death Audits in Tanzania
Published August 2026
We assessed the implementation of standardized pediatric mortality audits and associated programmatic responses on mortality trends among CLHIV in Tanzania.
View Resource
Topics:
Pediatric HIV,
Research
Countries:
Tanzania
Issue Briefs
Common Ground for Global Health Policy Brief: Pediatric HIV
Published June 2026
Overview Children* are disproportionately affected by the HIV epidemic yet are consistently deprioritized and underserved compared to other affected populations. UNAIDS’ global treatment targets call for 95% of people living with HIV to know their status; 95% of people who know their status to be on treatment; and 95% of people on treatment to sustain […]
View Resource
Topics:
Advocacy,
Pediatric HIV
Countries:
Global